NCT07730281 clinical trial report covering PRA-216, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07731828 clinical trial report covering Adebrelimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07729917 clinical trial report covering CAN016, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07730632 clinical trial report covering QLS7305, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07731919 clinical trial report covering ALX-1, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07729826 clinical trial report covering C-CAR168, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07731789 clinical trial report covering Tafasitamab-Cxix, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07731256 clinical trial report covering Semaglutide (Novo Nordisk), Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262928 clinical trial report covering Girocitinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262689 clinical trial report covering PTT-621, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262866 clinical trial report covering Qilong dingchuan Tablets, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262790 clinical trial report covering VB19055, Phase 2, endpoints, sponsor, geography, readout timing and development white space.